Key result
Pharmacotherapy targeting BP near 130/80 mmHg reduces cardiovascular events and mortality in diabetes.
Why the study?
Does pharmacological blood pressure control reduce cardiovascular events and mortality in patients with type 2 diabetes?
Population
Patients with type 2 diabetes mellitus and high blood pressure
Design
Review
Authors
Loading...
Supports lower BP targets in diabetic hypertension; leaves open confirmation from dedicated prospective trials.
Does pharmacological blood pressure control reduce cardiovascular events and mortality in patients with type 2 diabetes?
In patients with type 2 diabetes, blood pressure targets approaching 130/80 mmHg using proven drug classes are recommended to reduce cardiovascular events.
Vargas‐Uricoechea et al. (2018) conducted a review in Type 2 diabetes and hypertension. Blood pressure control was evaluated. Pharmacological therapy for hypertension in patients with diabetes should target blood pressure levels approaching 130/80 mmHg to reduce the risk of cardiovascular events and mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: